Luis Malpica Castillo
Department of Lymphoma - Myeloma, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2011 | Universidad Peruana Cayetano Heredia Facultad de Medicina, Lima, PER, MD, Medical Degree |
Postgraduate Training
| 2017-2020 | Clinical Fellowship, Hematology and Medical Oncology, University of North Carolina, Chapel Hill, NC |
| 2014-2017 | Clinical Residency, Internal Medicine, Jackson Memorial Hospital (JMH) /University of Miami (UM), Miami, FL |
| 2011-2014 | Clinical Fellowship, Infectious Disease, Universidad Peruana Cayetano Heredia, Lima |
Board Certifications
| 2020 | American Board of Internal Medicine, Medical Oncology |
| 2020 | American Board of Internal Medicine, Hematology |
| 2017 | American Board of Internal Medicine, Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Parasitology and Immunology Department, Universidad Peruana Cayetano Heredia, Alberto Hurtado School of Medicine, Lima, 2011 - 2013
Other Appointments/Responsibilities
Lecturer, University of North Carolina School of Medicine, Chapel Hill, NC, 2017 - 2020
Hematology/Oncology Fellow, University of North Carolina, Chapel Hill, NC, 2017 - 2020
Research Fellow, Dr. Armistead Laboratory, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, 2017 - 2020
Internal Medicine Residency, University of Miami/Jackson Memorial Hospital, Miami, FL, 2014 - 2017
Research Fellow, Dr. Ramos Laboratory, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, 2014 - 2017
Medical Assistant / Course Coordinator, Gorgas Course in Clinical Tropical Medicine, Lima, 2012 - 2014
Medical Assistant / Course Coordinator, Clinical Ultrasound Course in Tropical Medicine, Lima, 2012 - 2014
Primary Care Assistant, Vesalio Clinic, Lima, 2012 - 2014
Chief Physician, Villaleticia de Cajamarquilla" Health Care Center, Ministry of Health of Peru (MINSA), Lima, 2012 - 2013
Research Fellow, Institute of Tropical Medicine ‘Alexander von Humboldt’, Lima, 2011 - 2014
Medical Assistant / Research Fellow, Department of Pathology, Universidad Peruana Cayetano Heredia, Lima, 2011 - 2014
Honors & Awards
| 2022 | NKT cell lymphoma/leukemia Moonshot Program, The MD Anderson Moonshot Program |
| 2022 | Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research by the National Institute of Health, National Cancer Institute Program |
| 2022 | Nationally ranked top 1% provider, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2021 | Chike Springer Legacy Scholarship |
| 2021 | The Harold Amos Medical Faculty Development Program’ Award by the American Society of Hematology / Robert Wood Johnson Foundation |
| 2021 | Diversity in Clinical Trials Career Development Program Award by the Bristol Myers Squibb Foundation |
| 2020 | Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award |
| 2019 | Abstract Achievement Award |
| 2019 | North Carolina Oncology Association Outstanding Fellow Award |
| 2019 | Research Training Award for Fellows |
| 2019 | American Society of Clinical Oncology Young Investigator Award |
| 2017 | Abstract Achievement Award |
| 2017 | Ambulatory internal medicine resident of the year |
| 2016 | Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award |
| 2015 | Ambulatory internal medicine resident of the year |
| 2010 | US Naval Medical Research Unit - 6 (NAMRU-6) Award in Infectious Diseases |
Selected Publications
Peer-Reviewed Articles
- Malpica L, Moll S. Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases. Hematology Am Soc Hematol Educ Program 2020(1):319-327, 2020. PMID: 33275674.
- Beltrán BE, Villela L, Torres MA, Otero V, Fiad L, Peña C, Cabrera ME, León P, Idrobo H, Castro DA, Paredes S, Perdomo I, Abello V, Rojas C, Ramirez-Ibargüen A, Candelaria M, Pérez-Jacobo F, Montaño-Figueroa E, Best C, Goméz-De Leon A, Gómez-Almaguer D, Ruiz-Argüelles G, Hernández-Hernández J, Malpica L, Sotomayor EM, Castillo JJ, Latin American Group of Lymphoproliferative Disorders (Grupo de Estudio Latinoamericano de Linfoproliferativos [GELL]). A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL). Clin Lymphoma Myeloma Leuk 20(10):637-646, 2020. e-Pub 2020. PMID: 32513598.
- Malpica L, Mufuka B, Galeotti J, Tan X, Grover N, Clark SM, Beaven A, Muss H, Dittus C. A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas. Leuk Lymphoma 61(6):1508-1511, 2020. e-Pub 2020. PMID: 32037934.
- Malpica Castillo LE, Palmer S, Zhu A, Deal AM, Chen SL, Moll S. Incidence and time course of neutropenia in patients treated with rituximab-based therapy for non-malignant immune-mediated hematologic diseases. Am J Hematol 95(5):E117-E120, 2020. e-Pub 2020. PMID: 32017201.
- Malpica-Castillo LE, Palmer S, Zhu A, Deal AM, Chen SL, Moll S. Adherence to infectious disease screening and immunization guidelines when treating non-malignant immune-mediated hematologic disorders. Am J Hematol 95(3):E72-E75, 2020. e-Pub 2020. PMID: 31872481.
- Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol 145:102839, 2020. e-Pub 2019. PMID: 31877534.
- Malpica L, van Duin D, Moll S. Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders. Am J Hematol 94(12):1396-1412, 2019. PMID: 31571266.
- Meredith M. Nichols, Luis Malpica, Hyman B. Muss, Nathan D. Montgomery. Circulating lobular breast carcinoma masquerading as acute leukemia. Human Pathology 16, 2019.
- Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, Ramos JC. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. Blood Adv 2(6):607-620, 2018. PMID: 29545256.
Invited Articles
- Ospina A, Idrobo H, Malpica L.. Consensus of the Latin American Study Group of Lymphoproliferative Disorders (GELL) for the management of Lymphomas in a state of pandemic SARS CoV-2 COVID 19, 2020.
- Malpica, L.. The Who, What, and When of Immunizations, 2020.
- Malpica, L.. Putting the Brakes on Dismal Outcomes for Virus-Driven ATLL, 2020.
- Malpica, L.. Many patients with blood disorders don’t receive recommended vaccines and screenings, 2019.
- Malpica L, Moll S.. New Herpes Zoster Vaccine: What the Hematologist Needs to Know, 2018.
- Guerra H, Malpica L, Seas C.. The Institute of Tropical Medicine ‘Alexander Von Humboldt’: Past, Present and Future Projections, 2013.
Abstracts
- Malpica L, White AC, Leguia C, Freundt N, Barros N, Chian C, Antunez EA, Montes M. Regulatory T cells and IgE expression in duodenal mucosa of Strongyloides stercoralis and human T lymphotropic virus type 1 co-infected patients. PLoS Negl Trop Dis 13(6):e0007415, 2019. e-Pub 2019. PMID: 31170141.
Book Chapters
- Malpica L, Aleman M.. Cases of Hematology and Oncology. In: Spanish and the Medical Interview: Clinical Cases and Exam Review, 2020.
- Malpica L, Dittus C.. Adult T-Cell Leukemia/Lymphoma. In: Novel Therapeutics for Rare Lymphomas, 2019.